Skip Navigation

VAERS Bibliography - September 2005

  1. Preventable Measles Among U.S. Residents, 2001-2004.   MMWR Morb Mortal Wkly Rep; 54 (33): 817-820; August 26, 2005.

  2. 6th Canadian Immunization Conference. Montreal, Quebec, 5 to 8 December, 2004. Oral Scientific Abstracts.   Can Commun Dis Rep; 31 (15): 161-167; August 1, 2005.

  3. The Immunization Sentinel Site Program in Michigan.   Mich Med; 104 (4): 24; July, 2005.

  4. Tiered Use of Inactivated Influenza Vaccine in the Event of a Vaccine Shortage.   MMWR Morb Mortal Wkly Rep; 54 (30): 749-750; August 5, 2005.

  5. Adler, U. C. The Influence of Childhood Infections and Vaccination on the Development of Atopy: a Systematic Review of the Direct Epidemiological Evidence.   Homeopathy; 94 (3): 182-195; July, 2005.

  6. Agarwal, S.; Bhanot, A.; Goindi, G. Understanding and Addressing Childhood Immunization Coverage in Urban Slums.    Indian Pediatr; 42 (7): 653-663; July, 2005.

  7. Alp, H.; Altinkaynak, S.; Arikan, D.; Ozyazicioglu, N. Adolescent Immunization Rates and the Effect of Socio-Demographic Factors on Immunization in a Cosmopolitan City (ERZURUM) in the Eastern Turkey.   Health Policy; July 28, 2005. [Epub ahead of print]

  8. Arenz, S.; Schmitt, H. J.; Tischer, A.; von, Kries R. Effectiveness of Measles Vaccination After Household Exposure During a Measles Outbreak: a Household Contact Study in Coburg, Bavaria.   Pediatr Infect Dis J; 24 (8): 697-699; August, 2005.

  9. Baleta, A. African Conference Highlights Gaps in Vaccination.  Lancet Infect Dis; 5 (8): 472-473; August, 2005.

  10. Bauch, C. T. Imitation Dynamics Predict Vaccinating Behaviour.  Proc Biol Sci; 272 (1573): 1669-1675; August 22, 2005.

  11. Brownstein, J. S.; Kleinman, K. P.; Mandl, K. D. Identifying Pediatric Age Groups for Influenza Vaccination Using a Real-Time Regional Surveillance System.   Am J Epidemiol; August 17, 2005. [Epub ahead of print]

  12. Buchta, C.; Kormoczi, G.; Heinze, G.; Puhr, R.; Kompatscher, M.; Jungling, G.; List, J.; Macher, M.; Hocker, P.; Watkins-Riedel, T.; Dettke, M. Lack of Impact of ABO Blood Group or Corresponding Isoantibodies on the Immune Response After Rabies Vaccination.   Wien Klin Wochenschr; 117 (11-12): 412-416; June, 2005.

  13. Butler, D. Drugs Could Head Off a Flu Pandemic--but Only If We Respond Fast Enough.   Nature; 436 (7051): 614-615; August 4, 2005.

  14. Canning, H. S.; Phillips, J.; Allsup, S. Health Care Worker Beliefs About Influenza Vaccine and Reasons for Non-Vaccination--a Cross-Sectional Survey.   J Clin Nurs; 14 (8): 922-925; September, 2005.

  15. Cherif, H.; Landgren, O.; Konradsen, H. B.; Kalin, M.; Bjorkholm, M.  Poor Antibody Response to Pneumococcal Polysaccharide Vaccination Suggests Increased Susceptibility to Pneumococcal Infection in Splenectomized Patients With Hematological Diseases.   Vaccine; August 15, 2005. [Epub ahead of print]

  16. Cizman, M.; Pokorn, M.; Osredkar, D.  Re: Transverse Myelitis After Measles and Rubella Vaccination.   J Paediatr Child Health; 41 (8): 460; August, 2005.

  17. Davis, M. M.  Varicella Vaccine, Cost-Effectiveness Analyses, and Vaccination Policy.   JAMA; 294 (7): 845-846; August 17, 2005.

  18. Drake, M.  The Vaccination Registers: What Are They and What Can We Learn From Them?   Local Popul Stud; 74: 36-53; 2005.

  19. Enserink, M.  Avian Influenza. 'Pandemic Vaccine' Appears to Protect Only at High Doses.   Science; 309 (5737): 996; August 12, 2005.

  20. Gaudin, S.; Yazbeck, A. S.  Immunization in India 1993-1999: Wealth, Gender, and Regional Inequalities Revisited.   Soc Sci Med; August 4, 2005. [Pubmed ahead of print]

  21. Goldman, G. S.  Universal Varicella Vaccination: Efficacy Trends and Effect on Herpes Zoster.   Int J Toxicol; 24 (4): 205-213; July, 2005.

  22. Greenberg, D. P.  Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents.   Pediatr Infect Dis J; 24 (8): 721-728; August, 2005.

  23. Gupta, P.; Choudhury, P.  Meningococcemia Update Vaccination and Chemoprophylaxis.   Indian Pediatr; 42 (7): 641-644; July, 2005.

  24. Haas, D. M.; Flowers, C. A.; Congdon, C. L.  Rubella, Rubeola, and Mumps in Pregnant Women: Susceptibilities and Strategies for Testing and Vaccinating.   Obstet Gynecol; 106 (2): 295-300; August, 2005.

  25. Hammarlund, E.; Lewis, M. W.; Carter, S. V.; Amanna, I.; Hansen, S. G.; Strelow, L. I.; Wong, S. W.; Yoshihara, P.; Hanifin, J. M.; Slifka, M. K.  Multiple Diagnostic Techniques Identify Previously Vaccinated Individuals With Protective Immunity Against Monkeypox.   Nat Med; August 7, 2005. [Epub ahead of print]

  26. Harper, S. A.; Fukuda, K.; Uyeki, T. M.; Cox, N. J.; Bridges, C. B.  Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).   MMWR Recomm Rep; 54 (RR-8): 1-40; July 29, 2005.

  27. Hviid, A.; Wohlfahrt, J.; Stellfeld, M.; Melbye, M.  Childhood Vaccination and Nontargeted Infectious Disease Hospitalization.   JAMA; 294 (6): 699-705; August 10, 2005.

  28. Kim, S. H.; Yeo, S. G.; Jang, H. C.; Park, W. B.; Lee, C. S.; Lee, K. D.; Kim, H. B.; Kim, N. J.; Kim, Y. T.; Jee, Y.; Cho, H.; Oh, M. D.; Choe, K. W.  Clinical Responses to Smallpox Vaccine in Vaccinia-Naive and Previously Vaccinated Populations: Undiluted and Diluted Lancy-Vaxina Vaccine in a Single-Blind, Randomized, Prospective Trial.   J Infect Dis; 192 (6): 1066-1070; September 15, 2005.

  29. Kudva, I. T.; Griffin, R. W.; Garren, J. M.; Calderwood, S. B.; John, M.  Identification of a Protein Subset of the Anthrax Spore Immunome in Humans Immunized With the Anthrax Vaccine Adsorbed Preparation.   Infect Immun; 73 (9): 5685-5696; September, 2005.

  30. Labelle, C.; Macpherson, D. W.  Evaluation of Yellow Fever Vaccination Centers in Canada.   J Travel Med; 12 (4): 180-183; July, 2005.

  31. Lane, L.; Reynolds, A.; Ramsay, M.  When Should Vaccination Be Contraindicated in Children?   Drug Saf; 28 (9): 743-752; 2005.

  32. Longini, I. M., Jr.; Nizam, A.; Xu, S.; Ungchusak, K.; Hanshaoworakul, W.; Cummings, D. A.; Halloran, M. E.  Containing Pandemic Influenza at the Source.   Science; 309 (5737): 1083-1087; August 12, 2005.

  33. Maurer, W.  Death Following Hexavalent Vaccination.   Vaccine; August 9, 2005. [Epub ahead of print]

  34. May, S. A.; Netto, G.; Domiati-Saad, R.; Kasper, C.  Cutaneous Lymphoid Hyperplasia and Marginal Zone B-Cell Lymphoma Following Vaccination.   J Am Acad Dermatol; 53 (3): 512-516; September, 2005.

  35. Metlay, J. P.; Fishman, N. O.; Joffe, M.; Edelstein, P. H.  Impact of Pediatric Vaccination With Pneumococcal Conjugate Vaccine on the Risk of Bacteremic Pneumococcal Pneumonia in Adults.   Vaccine; August 24, 2005. [Epub ahead of print]

  36. Michel, R.; Garnotel, E.; Spiegel, A.; Morillon, M.; Saliou, P.; Boutin, J. P.  Outbreak of Typhoid Fever in Vaccinated Members of the French Armed Forces in the Ivory Coast.   Eur J Epidemiol; 20 (7): 635-642; 2005.

  37. Music, S.  Towards Universal Childhood Immunization: Why We Must and How We Might.   Vaccine; August 22, 2005. [Epub ahead of print]

  38. Oglesby, A.  Staying Healthy. Prevention Through Immunization.   Diabetes Self Manag; 22 (4): 48-50; July, 2005.

  39. Panhotra, B. R.; Saxena, A. K.  Negative Attitude of Health Care Workers Towards Childhood Vaccination Program.   Vaccine; August 23, 2005. [Epub ahead of print]

  40. Podewils, L. J.; Antil, L.; Hummelman, E.; Bresee, J.; Parashar, U. D.; Rheingans, R.  Projected Cost-Effectiveness of Rotavirus Vaccination for Children in Asia.   J Infect Dis; 192 Suppl 1:S133-45; September 1, 2005.

  41. Rosenthal, S. L.  Protecting Their Adolescents From Harm: Parental Views on STI Vaccination.   J Adolesc Health; 37 (3): 177-178; September, 2005.

  42. Rota, M. C.; D'Ancona, F.; Massari, M.; Mandolini, D.; Giammanco, A.; Carbonari, P.; Salmaso, S.; Atti, M. L.  How Increased Pertussis Vaccination Coverage Is Changing the Epidemiology of Pertussis in Italy.   Vaccine; August 17, 2005. [Epub ahead of print]

  43. Santos, A. P.; Bertho, A. L.; Dias, D. C.; Santos, J. R.; Marcovistz, R.  Lymphocyte Subset Analyses in Healthy Adults Vaccinated With Yellow Fever 17DD Virus.   Mem Inst Oswaldo Cruz; 100 (3): 331-337; May, 2005.

  44. Schmitt, H. J.; Siegrist, C. A.; Salmaso, S.; Law, B.; Booy, R.  B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination.   Vaccine; August 3, 2005. [Epub ahead of print]

  45. Simonsen, L.; Viboud, C.; Elixhauser, A.; Taylor, R. J.; Kapikian, A. Z.  More on RotaShield and Intussusception: The Role of Age at the Time of Vaccination.   J Infect Dis; 192 Suppl 1:S36-43; September 1, 2005.

  46. Soleimanjahi, H.; Bamdad, T.; Fotouhi, F.; Roustai, M. H.; Faghihzadeh, S.  Prevalence of HI Antibody Titer Against Rubella Virus to Determine the Effect of Mass Vaccination in Tehran.   J Clin Virol; July 30, 2005. [Epub ahead of print]

  47. Solomon, A. W.; Mabey, D. C.  Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydiatrachomatis.   Vaccine; August 22, 2005. [Epub ahead of print]

  48. Southern, J.; Crowley-Luke, A.; Borrow, R.; Andrews, N.; Miller, E.  Immunogenicity of One, Two or Three Doses of a Meningococcal C Conjugate Vaccine Conjugated to Tetanus Toxoid, Given As a Three-Dose Primary Vaccination Course in UK Infants at 2, 3 and 4 Months of Age With Acellular Pertussis-Containing DTP/Hib Vaccine.   Vaccine; August 17, 2005. [Epub ahead of print]

  49. Tabbarah, M.; Zimmerman, R. K.; Nowalk, M. P.; Janosky, J. E.; Troy, J. A.; Raymund, M.; Jewell, I. K.  What Predicts Influenza Vaccination Status in Older Americans Over Several Years?   J Am Geriatr Soc; 53 (8): 1354-1359; August, 2005.

  50. Vellozzi, C.; Lane, J. M.; Averhoff, F.; Maurer, T.; Norton, S.; Damon, I.; Casey, C.  Generalized Vaccinia, Progressive Vaccinia, and Eczema Vaccinatum Are Rare Following Smallpox (Vaccinia) Vaccination: United States Surveillance, 2003.   Clin Infect Dis; 41 (5): 689-697; September 1, 2005.

  51. von, Kries R.  Comment on B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination.   Vaccine; August 1, 2005. [Epub ahead of print]

  52. Weir, E.  Vaccination Boosts Adult Immunity to Varicella Zoster Virus.   CMAJ; 173 (3): 249; August 2, 2005.

  53. Wood, N.; Menzies, R.; McIntyre, P.  Epiglottitis in Sydney Before and After the Introduction of Vaccination Against Haemophilus Influenzae Type b Disease.   Intern Med J; 35 (9): 530-535; September, 2005.

  54. Wuorimaa, T. K.; Dagan, R.; Bailleux, F.; Haikala, R.; Ekstrom, N.; Eskola, J.; Yaich, M.; Kayhty, H.  Functional Activity of Antibodies After Immunization of Finnish and Israeli Infants With an 11-Valent Pneumococcal Conjugate Vaccine.   Vaccine; August, 2005. [Epub ahead of print]

  55. Zhou, F.; Harpaz, R.; Jumaan, A. O.; Winston, C. A.; Shefer, A.  Impact of Varicella Vaccination on Health Care Utilization.   JAMA; 294 (7): 797-802; August 17, 2005.